The acquisition includes an upfront cash payment of £458 million and performance-based contingent payments of up to £42 million
The collaboration will encompass NRT Brand Nicotinell and local variants Nicabate, Habitrol, and Thrive in local market outside US
Acquisition of the four brands, including Nicotinell, had overall sales of GBP 217 million
Open demat account in 5 minutes*